Advances in Pharmacological Treatments Including GnRH Antagonists and SPRMs for Fibroid Management
The pharmacological landscape for fibroids has been revolutionized by the introduction of new agents offering effective non-surgical management. Pharmacological Treatments are now dominated by oral GnRH (Gonadotropin-Releasing Hormone) antagonists, such as elagolix and relugolix, often administered in combination with low-dose estrogen and progestin ("add-back therapy"). These antagonists...
0 Reacties 0 aandelen 463 Views 0 voorbeeld